|
Viewpoint
Health Care Policy and Law
The UK Delivers a Tobacco-Free Generation—But Is the Real Prize Global?
Sarah E. Jackson, PhD; Hazel Cheeseman, MSc; Jamie Brown, PhD
Original Investigation
Evaluation of Intervention Strategies to Improve Follow-Up Colonoscopy After Abnormal FIT/FOBT Result: A Systematic Review and Meta-Analysis
Wei Yu Chua, MBBS; Luke Xavier Chew, MBBS; Claire K. M. Chan, MBBS; et al.
Editor's Note: From Positive FIT Result to Colonoscopy—Closing a Gap in Care; Cary P. Gross, MD; Ilana B. Richman, MD, MHS
Temporary Cessation of DMARD Therapy and COVID-19 Supplemental Dose Vaccine Immunogenicity in Patients With Inflammatory Arthritis: The COVER Randomized Clinical Trial
Jeffrey R. Curtis, MD, MS, MPH; Amy S. Mudano, MPH; Gary Cutter, PhD; et al.
Invited Commentary
Not All Immunosuppressive Agents Need to Be Interrupted During COVID-19 Vaccination
Jin Kyun Park, MD, PhD; Eun Bong Lee, MD, PhD
Editor's Note
From Positive FIT Result to Colonoscopy—Closing a Gap in Care
Cary P. Gross, MD; Ilana B. Richman, MD, MHS
Research Letter
Health Care Policy and Law
Expiration of COVID-19 Pandemic Food Assistance and Food Insufficiency in Adults With Disabilities
Banushree Jawaharlal Nehru, MBBS, MPH; Tarang Parekh, PhD, MBBS
FROM JAMA THIS WEEK
Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial
Joanna L. Hart, MD; Anil Vachani, MD; Christine M. Neslund-Dudas, PhD; et al
Lean MASLD and Limits of Body Size in Risk Stratification
Elisabetta Bugianesi, MD, PhD
Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease
Leyla de Avila, MS; Khalid M. AlNaamani, MD; Margarita Papatheodoridi, MD; et al
Postpartum Initiation of GLP-1 Receptor Agonists Among Commercially Insured Women in the US
Sih-Ting Cai, PhD; Kosali Simon, PhD; Anthony L. Shanks, MD; et al
Comment & Response
Landmark Significance and Future Directions of the RAPID-TEST Trial—Core Limitations and Advanced Pathways
Weifeng Yang, MB; Yaling Li, MD; Jun Li, MD
Landmark Significance and Future Directions of the RAPID-TEST Trial—Core Limitations and Advanced Pathways—Reply
Alastair D. Hay, MD
|